Question for biotech investors: If ObamaCare is rescinded, will the federal government be ordered to issue refunds to drug and medical-device companies for the ObamaCare fees that were collected, including those based on market share (#msg-49486773)?
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.